From: Tumor lysis syndrome following trastuzumab and pertuzumab for metastatic breast cancer: a case report
Variable
Value
Change from baseline value
Uric acid
≥8 mg/dL (476 mmol/L)
25 % increase
Potassium
≥6 mEq/L (or 6 mmol/L)
Phosphorus
≥4.5 mg/dL (1.45 mmol/L)
Calcium
≤7 md/dl (1.75 mmol/L)